CANOPY: Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (clinicaltrials.gov) - Sep 9, 2026 - P2 | N=47 | Active, not recruiting | Sponsor: Rana McKay, MD | Trial completion date: Jul 2027 ➔ Oct 2027 | Trial primary completion date: Jul 2026 ➔ Oct 2026
Trial completion date • Trial primary completion date • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor • CD4
|